News
Parents won't be able to vaccinate healthy children 6 months to 5 years old if the FDA pulls Pfizer's COVID-19 vaccine authorization.
9h
TipRanks on MSNBioNTech’s BNT327 Trial: A New Hope for Small-cell Lung Cancer?
The intervention being tested is BNT327, administered in two dose levels, combined with standard chemotherapy drugs such as etoposide, carboplatin, paclitaxel, and topotecan. The purpose is to ...
9h
TipRanks on MSNBioNTech’s Latest Clinical Study: A New Hope for Advanced Breast Cancer Treatment
The update on this clinical study could influence BioNTech’s stock performance by potentially boosting investor confidence if the results are favorable. The involvement of collaborators like ...
The Food and Drug Administration could pull Pfizer's coronavirus vaccine emergency authorization for children under age 5.
Detailed price information for Biontech Se ADR (BNTX-Q) from The Globe and Mail including charting and trades.
Detailed price information for Sutro Biopharma Inc (STRO-Q) from The Globe and Mail including charting and trades.
Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...
Showing that his loyalty to his own anti-vax mentality is greater than his loyalty to Donald Trump, Robert F. Kennedy Jr., the dangerous quack atop the Department of Health and Human Services, has ...
Pediatrician Deborah Greenhouse writes that South Carolina is at risk because of the U.S. government’s decision to defund almost $500 million in mRNA vaccine research funding.
8h
GlobalData on MSNElicio’s peptide cancer vaccine shows survival benefit in Phase I trial
Elicio's mKRAS-targeting cancer vaccine reduced the risk of death by 77% by activating the anti-tumour mechanisms of key ...
Discover PDS Biotechnology's Q2 2025 progress on groundbreaking cancer trials, including VERSATILE-003. Explore durable outcomes and market growth potential.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results